746
Participants
Start Date
April 7, 2021
Primary Completion Date
April 20, 2022
Study Completion Date
April 27, 2022
Moderna COVID-19 Vaccine
Intramuscular injection
Pfizer-BioNTech COVID-19 Vaccine
Intramuscular injection
Placebo
Intramuscular injection
Mount Sinai Hospital, Department of Medicine, Division of Clinical Immunology, New York
Columbia University Irving Medical Center, New York
Rochester Regional Health, Rochester
Penn State Health Allergy, Milton S. Hershey Medical Center, Hershey
Johns Hopkins Bayview Medical Center, Baltimore
University of Virginia Health System: Department of Medicine, Division of Allergy and Immunology, Charlottesville
Virginia Commonwealth University, Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology, Richmond
North Carolina Translational and Clinical Sciences Institute-Clinical & Translational Research Center (CTRC) at the University of North Carolina at Chapel Hill, Chapel Hill
Emory University School of Medicine, Emory Healthcare: Emory Clinic Allergy and Immunology, Atlanta
University Health, University of Miami Health System, Miami
University of South Florida Asthma Allergy and Immunology Clinical Research Unit, Tampa
Vanderbilt University Medical Center, Nashville
Cleveland Clinic, Allergy & Clinical Immunology, Cleveland
University of Michigan Health, Ann Arbor
Henry Ford Hospital and Health System, Detroit
University of Iowa Health Care, Iowa City
University of Wisconsin Asthma Allergy Pulmonary Research, Madison
NorthShore University HealthSystem, Dermatology Clinical Trials Unit, Skokie
Sinus and Allergy Center of Northwestern University, Chicago
Saint Louis University Care Center for Specialized Medicine, St Louis
Arkansas Children's, University of Arkansas for Medical Sciences, Little Rock
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine Medical Center, Houston
National Jewish Health, Denver
University of Arizona Health Sciences, College of Medicine Tucson, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Tucson
University of California, Los Angeles Medical Center, Los Angeles
Stanford Medicine, Sean N. Parker Center for Allergy & Asthma Research, Stanford
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Immune Tolerance Network (ITN)
NETWORK
Rho Federal Systems Division, Inc.
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH